BackPhaseBio Pharmaceuticals Overview
PhaseBio Pharmaceuticals Inc

PhaseBio Pharmaceuticals Target Price

See how PHAS's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.07

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside

PhaseBio Pharmaceuticals (PHAS) FAQ

Stockcircle tracks target price for PhaseBio Pharmaceuticals (PHAS), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for PhaseBio Pharmaceuticals's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main PHAS overview so you can move from this figure to the surrounding analysis quickly.